Black, D.M., Reid, I.R., Cauley, J.A., Cosman, F., Leung, P.C., Lakatos, P., et al. (2015) The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Secondextension to the Horizon-Pivotal Fracture Trial (PFT). American Society for Bone and Mineral Research, 30, 934-944.
https://doi.org/10.1002/jbmr.2442

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.